Drug Type Synthetic peptide |
Synonyms- |
Target |
Mechanism GCGR agonists(Glucagon receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Preclinical | DE | - | |
Diabetes Mellitus, Type 2 | Preclinical | DE | - | |
Diabetes Mellitus, Type 2 | Preclinical | SE | - |